Brief: 22nd Century Group Acquires GVB Biopharma, A Hemp/Cannabis Company
May 13 (Reuters) - 22nd Century Group Inc XXII.O :
* 22ND CENTURY GROUP (NASDAQ: XXII) ACQUIRES GVB BIOPHARMA,
A
LEADING HEMP/CANNABIS COMPANY
* 22ND CENTURY GROUP INC - TRANSACTION IMMEDIATELY ACCRETIVE
Source text for Eikon: ID:nGNXJHCmP
Further company coverage: XXII.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 22nd Century
See all newsNASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: FDA To Review Two Modified Risk Tobacco Product Renewal Applications From 22nd Century Group
22nd Century Group Q4 losses narrow on market expansion, improved margins